Pharmacy
Majmudar's role within the company has yet to be announced, but he arrives from the Healthcare Transformation Lab.
The amendment would give funding to the Department of Health and Human Services to require drug pricing in direct-to-consumer advertising.
The pharma industry is skating to where they know the puck is going on drug price transformation, HHS Secretary Alex Azar says.
Eligible consumers will be able to use their over-the-counter allowance on medications and health-related items such as first- aid supplies, support braces, and pain relievers.
One of the main ways drug spending is mitigated is through market competition from biosimilar and generic drugs.
Competition drives drug prices and results in higher rebates, insurance organization says.
The conspiracy involving secret meetings resulted in higher prices for insurers, the government and consumers, the lawsuit claims.
Investor Carl Icahn says he will vote against $54 billion PBM acquisition as being too high a price.
The merger would increase market concentration in the PBM space and put other insurers at a competitive disadvantage, Dave Jones says.
Announcement comes less than two months after a scathing report from the Office of the Inspector General showing skyrocketing Medicare Part D drug spending.